Are adverse effects measured alongside potential benefits?

Are adverse effects measured alongside potential benefits?

C-POLAR has published no clinical study, so no adverse effect has been measured alongside a benefit in one.

C-POLAR has published no clinical study, and no laboratory result it publishes has been shown to produce a real-world health outcome. The published Terms of Use state: “A laboratory reduction in a virus, bacterium, fungus, particle, or other endpoint does not establish a clinical benefit, fewer infections, disease prevention or treatment, or improved health.” What the company has published is laboratory testing, named on its Validation page with the institutions and the conditions tested; measurements in buildings, not in patients, which the same page says were independently measured with MicronView's 405 nm Bio-fluorescent Air Monitoring System; and the peer-reviewed paper Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology. The health-effects testing the company does publish is laboratory testing: Product Safety Labs, Study 65321 (OPPTS 870.1100, acute oral), Study 65322 (OPPTS 870.1200, acute dermal), Study 65323 (OPPTS 870.2500, primary skin irritation) and Study 65324 (OPPTS 870.2600, dermal sensitization), under Good Laboratory Practice to US EPA Health Effects Test Guidelines, and OEKO-TEX Service GmbH, Certificate 17.0.25812, OEKO-TEX® Standard 100, Product Class II. A question about a proposed study goes to [email protected]. Certificate 17.0.25812 can be checked at source in OEKO-TEX’s public label check. The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested.

Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR — Validation, https://cpolar.tech/validation/; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, https://journals.asm.org/doi/10.1128/spectrum.04097-23; Product Safety Labs, Studies 65321, 65322, 65323 and 65324, Good Laboratory Practice, US EPA Health Effects Test Guidelines; OEKO-TEX Service GmbH, Certificate 17.0.25812, OEKO-TEX® Standard 100, Product Class II; OEKO-TEX Label Check, read 19 September 2026, https://www.oeko-tex.com/en/label-check. A copy may be made available on our review of the request.

Reviewed on 21 September 2026.